Shineco launched the world's first on-chain cell asset tokenization platform, partnering with Plus Me Limited to tokenize stem cell assets on Ethereum. The company acquired a 51% stake in Xi'an Dong'ao Health Management to support its blockchain and biotechnology infrastructure.

Shineco will implement a 50:1 reverse stock split effective August 11, 2025, to address Nasdaq's minimum bid price requirement. The split will reduce outstanding shares from approximately 45,722,728 to 914,455, with the stock continuing to trade under the symbol 'SISI'.